Solventum Corp (SOLV)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NYSE
$91.90
+1.04%
Investru Score
55.8 / 100
Good
Why is SOLV moving?
SOLV is up 1.04% today, in line with its broader uptrend.
Business overview
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bull case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bear case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Want the complete AI research memo? Unlock full stock analysis →
Score breakdown
- Financial Quality
- 47
- Growth
- 44
- Profitability
- 62
- Balance Sheet
- 43
- Valuation
- 69
- Momentum
- 91
Financial quality
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- ROIC
- 15.4%
- ROE
- 30.8%
- FCF Margin
- -0.1%
- Free Cash Flow (TTM)
- $-0.0B
- Earnings Quality (OCF ÷ Net Income)
- 0.2x
Valuation
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- P/E (TTM)
- 10.9x
- Forward P/E
- Data unavailable
- PEG (P/E ÷ EPS Growth)
- 0.0x
- Company Median PEG
- 0.0x
- Price / Sales
- 1.9x
- EV / EBITDA
- 8.7x
- FCF Yield
- -0.1%
Key risks
- AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.(Probability: Medium · Impact: Medium)
Latest earnings
- Q2 FY26 EPS
- $0.53
- Estimate
- Data unavailable
- Surprise
- Data unavailable
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
SEC filings
- 10-Q · Q2 FY26 · period ended 2026-06-30Filed 2026-08-05
- 10-Q · Q1 FY26 · period ended 2026-03-31Filed 2026-05-05
- 10-K · FY25 · period ended 2025-12-31Filed 2026-02-27
- 10-Q · Q3 FY25 · period ended 2025-09-30Filed 2025-11-06
- 10-Q · Q2 FY25 · period ended 2025-06-30Filed 2025-08-08
- 10-K · FY24 · period ended 2022-12-31Filed 2025-02-28
- 10-K · FY24 · period ended 2023-12-31Filed 2025-02-28
- 10-K · FY24 · period ended 2024-12-31Filed 2025-02-28
Event filings (8-K) aren't covered by this page's data source yet — only 10-K/10-Q are shown above.
Market cap $15.9B · 52-week range $62.38–$94.16 · market data as of Sep 2, 2026, 4:00 PM ET · latest SEC filing: 2026-08-05
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze SOLV with Investru AINot investment advice. Investru AI summarizes public data and AI-generated analysis for informational purposes only.